Eleni Timotheadou

2.3k total citations
76 papers, 1.0k citations indexed

About

Eleni Timotheadou is a scholar working on Oncology, Reproductive Medicine and Cancer Research. According to data from OpenAlex, Eleni Timotheadou has authored 76 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Oncology, 20 papers in Reproductive Medicine and 19 papers in Cancer Research. Recurrent topics in Eleni Timotheadou's work include Ovarian cancer diagnosis and treatment (19 papers), Cancer Treatment and Pharmacology (13 papers) and HER2/EGFR in Cancer Research (12 papers). Eleni Timotheadou is often cited by papers focused on Ovarian cancer diagnosis and treatment (19 papers), Cancer Treatment and Pharmacology (13 papers) and HER2/EGFR in Cancer Research (12 papers). Eleni Timotheadou collaborates with scholars based in Greece, United Kingdom and Germany. Eleni Timotheadou's co-authors include George Fountzilas, Dimitrios Pectasides, Gerasimos Aravantinos, Pavlos Papakostas, Helen Gogas, Konstantine T. Kalogeras, Christos Christodoulou, Kate Hall, Helena Linardou and Roger A’Hern and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Eleni Timotheadou

69 papers receiving 1.0k citations

Peers

Countries citing papers authored by Eleni Timotheadou

Since Specialization

Citations

This map shows the geographic impact of Eleni Timotheadou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eleni Timotheadou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eleni Timotheadou more than expected).

Fields of papers citing papers by Eleni Timotheadou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eleni Timotheadou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eleni Timotheadou. The network helps show where Eleni Timotheadou may publish in the future.

Co-authorship network of co-authors of Eleni Timotheadou

This figure shows the co-authorship network connecting the top 25 collaborators of Eleni Timotheadou. A scholar is included among the top collaborators of Eleni Timotheadou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eleni Timotheadou. Eleni Timotheadou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prognostic Factors in the Treatment of Advanced Endometrial Cancer Patients: 12-Year Experience of an ESGO Certified Center 2026 ·Cancers ·Dimitrios Zouzoulas, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Eleni Timotheadou, (unknown), (unknown)	0
2	Neutrophil–Lymphocyte Ratio and KELIM Score as Prognostic Markers in High-Grade Serous Advanced Ovarian Cancer Patients Treated with Neoadjuvant Chemotherapy 2025 ·Biomedicines ·(unknown), (unknown), Κimon Chatzistamatiou, (unknown), Dimitrios Zouzoulas, (unknown), Christos Anthoulakis, Theodoros Moysiadis, (unknown), Eleni Timotheadou, (unknown), Dimitrios Tsolakidis	1
3	Microsatellite Stable Colorectal Tumours in Patients with Lynch Syndrome: A Case Report and Systematic Review Analysing Clinical Features and Implications for Immunotherapy 2025 ·Journal of Gastrointestinal Cancer ·(unknown), Davide Mauri, (unknown), Konstantinos Katsanos, Eleni Timotheadou, (unknown), Konstantinos Kamposioras	1
4	The Use of CA-125 KELIM to Identify Which Patients Can Achieve Complete Cytoreduction after Neoadjuvant Chemotherapy in High-Grade Serous Advanced Ovarian Cancer 2024 ·Cancers ·Dimitrios Zouzoulas, Dimitrios Tsolakidis, (unknown), (unknown), Κimon Chatzistamatiou, (unknown), (unknown), Eleni Timotheadou, Grigoris Grimbizis	8
5	Narrative Review of Drug-Associated Nail Toxicities in Oncologic Patients 2023 ·Dermatology Practical & Conceptual ·(unknown), (unknown), Chryssoula Papageorgiou, (unknown), (unknown), (unknown), (unknown), (unknown), Eleni Timotheadou, Anastasia Trigoni, (unknown), Elizabeth Lazaridou, Zoé Apalla, Myrto Trakatelli	4
6	The Contribution of Lipidomics in Ovarian Cancer Management: A Systematic Review 2023 ·International Journal of Molecular Sciences ·Vassiliki Tzelepi, Helen Gika, Olga Begou, Eleni Timotheadou	3
7	The Contribution of Lipidomics in Ovarian Cancer Management: A Systematic Review 2023 ·Preprints.org ·Vassiliki Tzelepi, Helen Gika, Olga Begou, Eleni Timotheadou	1
8	Investigating Predictive Factors of Dysphagia and Treatment Prolongation in Patients with Oral Cavity or Oropharyngeal Cancer Receiving Radiation Therapy Concurrently with Chemotherapy 2023 ·Current Oncology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Petros Bangeas, Eleni Timotheadou	7
9	A retrospective multicentric cohort study of checkpoint inhibitors‐induced pruritus with focus on management 2023 ·Photodermatology Photoimmunology & Photomedicine ·Chryssoula Papageorgiou, Elizabeth Lazaridou, Konstantinos Lallas, (unknown), Vasiliki Nikolaou, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), George Lazaridis, Dimitrios Dionysopoulos, Aimilios Lallas, (unknown), Christina Fotiadou, Eleni Timotheadou, Zoé Apalla	2
10	Metastatic or locally advanced breast cancer patients: towards an expert consensus on nab-paclitaxel treatment in HER2-negative tumours—the MACBETH project 2018 ·Cancer Chemotherapy and Pharmacology ·(unknown), Marina Elena Cazzaniga, Eva Ciruelos, Alessandra Fabi, José Á. García-Sáenz, Henrik Lindman, D. Mavroudis, Christian Schem, G. Steger, Eleni Timotheadou, Khalil Zaman, Valter Torri	2
11	Evaluation of the prognostic significance of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) validation study 2015 ·Journal of Translational Medicine ·Αngelos Koutras, Konstantine T. Kalogeras, Ralph M. Wirtz, Zoi Alexopoulou, Mattheos Bobos, Flora Zagouri, Elke Veltrup, Eleni Timotheadou, Helen Gogas, George Pentheroudakis, (unknown), Christina Μagkou, Christos Christodoulou, Dimitrios Bafaloukos, Pavlos Papakostas, Gerasimos Aravantinos, Dimitrios Pectasides, Haralabos P. Kalofonos, George Fountzilas	12
12	Lessons from the past: Long-term safety and survival outcomes of a prematurely terminated randomized controlled trial on prophylactic vs. hemoglobin-based administration of erythropoiesis-stimulating agents in patients with chemotherapy-induced anemia 2015 ·Molecular and Clinical Oncology ·Giannis Mountzios, Gerasimos Aravantinos, Zoi Alexopoulou, Eleni Timotheadou, (unknown), Christos Christodoulou, (unknown), Eleni Galani, Αngelos Koutras, Dimitrios Bafaloukos, Helena Linardou, Dimitrios Pectasides, Ioannis Varthalitis, Pavlos Papakostas, Haralabos P. Kalofonos, George Fountzilas	10
13	p85 Protein Expression is Associated with Poor Survival in HER2-Positive Patients with Advanced Breast Cancer Treated with Trastuzumab 2014 ·Pathology & Oncology Research ·Kitty Pavlakis, Mattheos Bobos, Anna Batistatou, Vassiliki Kotoula, Anastasia G Eleftheraki, (unknown), Eleni Timotheadou, George Pentheroudakis, Amanda Psyrri, Αngelos Koutras, Dimitrios Pectasides, Pavlos Papakostas, Evangelia Razis, Christos Christodoulou, Konstantine T. Kalogeras, George Fountzilas	5
14	The androgen receptor as a surrogate marker for molecular apocrine breast cancer subtyping 2014 ·The Breast ·Sotiris Lakis, Vassiliki Kotoula, Anastasia G Eleftheraki, Anna Batistatou, Mattheos Bobos, Triantafyllia Κoletsa, Eleni Timotheadou, Sofia Chrisafi, George Pentheroudakis, Αngelos Koutras, Flora Zagouri, Helena Linardou, George Fountzilas	23
15	Differential Expression of the Insulin-Like Growth Factor Receptor among Early Breast Cancer Subtypes 2014 ·PLoS ONE ·Giannis Mountzios, (unknown), Ioannis Kostopoulos, Helen P. Kourea, George Kouvatseas, Eleni Timotheadou, Pantelis Zebekakis, Ioannis Efstratiou, Helen Gogas, (unknown), Sofia Chrisafi, (unknown), George Pentheroudakis, Αngelos Koutras, Eleni Galani, Dimitrios Bafaloukos, George Fountzilas	15
16	Ixabepilone Administered Weekly or Every Three Weeks in HER2-Negative Metastatic Breast Cancer Patients; A Randomized Non-Comparative Phase II Trial 2013 ·PLoS ONE ·George Fountzilas, Vassiliki Kotoula, Dimitrios Pectasides, George Kouvatseas, Eleni Timotheadou, Mattheos Bobos, (unknown), Christos Papadimitriou, Eleni Vrettou, (unknown), Αngelos Koutras, Evangelia Razis, Dimitrios Bafaloukos, Epaminontas Samantas, George Pentheroudakis, Dimosthenis Skarlos	11
17	Prognostic significance of UBE2C mRNA expression in high-risk early breast cancer. A Hellenic Cooperative Oncology Group (HeCOG) Study 2011 ·Annals of Oncology ·Amanda Psyrri, Konstantine T. Kalogeras, Ralf Kronenwett, Ralph M. Wirtz, Anna Batistatou, Evangelos Bournakis, Eleni Timotheadou, Helen Gogas, Gerasimos Aravantinos, Christos Christodoulou, Thomas Makatsoris, Helena Linardou, Dimitrios Pectasides, Nicholas Pavlidis, Theofanis Economopoulos, George Fountzilas	61
18	Pegfilgrastim Administered on the Same Day with Dose-Dense Adjuvant Chemotherapy for Breast Cancer Is Associated with a Higher Incidence of Febrile Neutropenia as Compared to Conventional Growth Factor Support: Matched Case-Control Study of the Hellenic Cooperative Oncology Group 2009 ·Oncology ·Dimosthenis Skarlos, Eleni Timotheadou, Eleni Galani, E. Samantas, Irene Grimani, Evangelos Lianos, Gerasimos Aravantinos, Ioannis Xanthakis, George Pentheroudakis, Dimitrios Pectasides, George Fountzilas	25
19	Evaluation of the prognostic and predictive value of HER family mRNA expression in high-risk early breast cancer: A Hellenic Cooperative Oncology Group (HeCOG) study 2008 ·British Journal of Cancer ·Αngelos Koutras, Konstantine T. Kalogeras, Meletios Α. Dimopoulos, Ralph M. Wirtz, Urania Dafni, Evangelos Briasoulis, Dimitrios Pectasides, Helen Gogas, Christos Christodoulou, Gerasimos Aravantinos, George Zografos, Eleni Timotheadou, Pavlos Papakostas, Helena Linardou, Evangelia Razis, Theofanis Economopoulos, Haralabos P. Kalofonos, George Fountzilas	53
20	Prognostic significance of HER-2, p53 and Bcl-2 in patients with epithelial ovarian cancer. 2007 ·PubMed ·Vassiliki Malamou‐Mitsi, (unknown), Eleni Timotheadou, Gerasimos Aravantinos, Eleni Vrettou, Niki J. Agnantis, George Fountzilas	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact